ExploreWatchlistsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Provision for income taxes

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Market cap
$41.2B
P/E ratio
133.3x
SummaryFinancials
Period EndProvision for income taxes (Million USD)YoY (%)
Dec 31, 20259-109.48%
Dec 31, 2024-99-1580.60%
Dec 31, 20237+59.52%
Dec 31, 20224+500.00%
Dec 31, 20211-74.07%
Dec 31, 20203+200.00%
Dec 31, 20191+9.36%
Dec 31, 20181-130.54%
Dec 31, 2013-3-74.51%
Dec 31, 2012-11-2156.81%
Dec 31, 20101

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat